Celyad Receives Additional €2.5 Million in Non-Dilutive Funding

Celyad Receives Additional €2.5 Million in Non-Dilutive Funding

Celyad Announces Board of Directors Evolution with New Appointment

Celyad Announces Board of Directors Evolution with New Appointment

Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights

Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights

Celyad Announces Closing of $20 Million Global Offering

Celyad Announces Closing of $20 Million Global Offering

Celyad Announces Pricing of $20.0 Million Global Offering

Celyad Announces Pricing of $20.0 Million Global Offering

Celyad Announces Launch of Proposed Global Offering

Celyad Announces Launch of Proposed Global Offering

Celyad Reports Half Year 2019 Financial Results and Second Quarter Business Highlights

Celyad Reports Half Year 2019 Financial Results and Second Quarter Business Highlights

Celyad Announces First Quarter 2019 Financial Results and Recent Business Highlights

Celyad Announces First Quarter 2019 Financial Results and Recent Business Highlights

Celyad Reports Business Update and Full Year 2018 Financial and Operating Results

Celyad Reports Business Update and Full Year 2018 Financial and Operating Results

Celyad Appoints Filippo Petti as Chief Executive Officer

Celyad Appoints Filippo Petti as Chief Executive Officer

Celyad Announces Third Quarter 2018 Business Update

Celyad Announces Third Quarter 2018 Business Update

Celyad Presents Update on CYAD-01 Solid Tumor Clinical Program at the SITC 33rd Annual Meeting

Celyad Presents Update on CYAD-01 Solid Tumor Clinical Program at the SITC 33rd Annual Meeting